Novel sample preparation technology identified as an important innovation for company’s cancer screening tests, and for external clinicians and researchers. (Aug. 11, 2017) Click to view
News Releases
Preora’s Product Development Company Receives ISO 13485 Quality Certification
Company takes critical step in the commercialization of its PWS NanocytologyTM cancer screening technology platform. (Aug. 3, 2017) Click to view
Preora Diagnostics to Present at AdvaMed 2015: The MedTech Conference
Preora President and CEO John W. Hart will participate in the prestigious “Innovation Showcase” at AdvaMed 2015 on October 7.
Click here to read the full story.
Preora to Present at AdvaMed_09.10.15
Preora Diagnostics to Commercialize Cancer Pre-screening Tests
NanoCytomics LLC today announced the formation of Preora Diagnostics Inc., a privately held medical technology company that will bring low-cost cancer pre-screening tests to primary care physicians in the U.S. and other select markets.
Click here to read the full story.
Preora Launch Release
NanoCytomics Earns Spot in Chicago’s MATTER Community
MATTER, Chicago’s new entrepreneurship and innovation hub for next-generation health IT, medical device, diagnostics and biopharma companies, has named NanoCytomics as an early member of its expanding community.
Click here to read the full story.
MATTER News Release
NanoCytomics President John W. Hart Profiled in White City News
On the day of the July 17 announcement of John Hart joining NanoCytomics as president, and again as the lead story in its July 21 weekly news roundup, White City News profiled John W. Hart in an exclusive interview with the influential Chicago life sciences blog.
Click here to read the full story.
White City News Article
NanoCytomics Names John W. Hart President, Announces Commercialization Plans
NanoCytomics President John Hart brings to the company 35 years of experience in various healthcare sectors, including more than two decades at Baxter International, Allegiance and Cardinal Health.
Click here to read the full story.
NanoCytomics News Release